Moderna’s RSV vaccine gets positive opinion from EU advisory panel
The vaccine, called mResvia, has already been approved by the U.S. Food and Drug Administration, becoming Moderna’s second approved product after its COVID-19 vaccine, Spikevax.
Immigration will have an effect on your retirement — but it’s probably not what you think.
New York State may approach $1 billion in legal pot sales this year as its legal cannabis business gains traction...
New Nike CEO Elliot Hill is inheriting “a turnaround that has yet to show momentum,” according to Stifel analyst Jim...
Analysts sees a potential spinoff of FedEx’s freight business as a possible boost, but the stock is dropping sharply
Get peace of mind, plus a piece of the action
Fed commentary could give a further shot in the arm to AI names that have been market leaders, but the...